147 related articles for article (PubMed ID: 25075794)
1. Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway.
Qu Q; Qu J; Guo Y; Zhou BT; Zhou HH
Anticancer Drugs; 2014 Oct; 25(9):1016-27. PubMed ID: 25075794
[TBL] [Abstract][Full Text] [Related]
2. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
[TBL] [Abstract][Full Text] [Related]
3. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
[TBL] [Abstract][Full Text] [Related]
4. Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines.
Qu Q; Qu J; Zhan M; Wu LX; Zhang YW; Lou XY; Fu LJ; Zhou HH
PLoS One; 2013; 8(10):e76474. PubMed ID: 24146874
[TBL] [Abstract][Full Text] [Related]
5. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
Chian S; Li YY; Wang XJ; Tang XW
Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of OCTN2 by cytokines plays an important role in the progression of inflammatory bowel disease.
Li P; Wang Y; Luo J; Zeng Q; Wang M; Bai M; Zhou H; Wang J; Jiang H
Biochem Pharmacol; 2020 Aug; 178():114115. PubMed ID: 32579962
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
8. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
9. Regulation of protein expression and function of octn2 in forskolin-induced syncytialization in BeWo Cells.
Huang FD; Kung FL; Tseng YC; Chen MR; Chan HS; Lin CJ
Placenta; 2009 Feb; 30(2):187-94. PubMed ID: 19091402
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
11. SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway.
Yao Y; Li L; Huang X; Gu X; Xu Z; Zhang Y; Huang L; Li S; Dai Z; Li C; Zhou T; Cai W; Yang Z; Gao G; Yang X
FEBS J; 2013 Jul; 280(14):3244-55. PubMed ID: 23615374
[TBL] [Abstract][Full Text] [Related]
12. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells.
Jang CH; Moon N; Oh J; Kim JS
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987009
[TBL] [Abstract][Full Text] [Related]
13. Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of Cyclin A and Cyclin D1 in colorectal cancer cells.
Yang C; Liu HZ; Fu ZX
Oncol Rep; 2012 Sep; 28(3):1006-12. PubMed ID: 22710431
[TBL] [Abstract][Full Text] [Related]
14. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
Zhou X; Wen G; Ringseis R; Eder K
J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ
Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328
[TBL] [Abstract][Full Text] [Related]
16. Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway.
Luo J; Qu J; Yang R; Ge MX; Mei Y; Zhou BT; Qu Q
Front Pharmacol; 2016; 7():189. PubMed ID: 27445823
[TBL] [Abstract][Full Text] [Related]
17. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron.
Wen G; Ringseis R; Eder K
Biochem Pharmacol; 2010 Mar; 79(5):768-76. PubMed ID: 19819229
[TBL] [Abstract][Full Text] [Related]
18. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
[TBL] [Abstract][Full Text] [Related]
19. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
[TBL] [Abstract][Full Text] [Related]
20. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation.
Park HS; Kim SH; Kim YS; Ryu SY; Hwang JT; Yang HJ; Kim GH; Kwon DY; Kim MS
Biofactors; 2009; 35(4):373-9. PubMed ID: 19353690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
